Tin tức & Cập nhật

Severe hypoglycaemia ups risk of adverse outcomes in older patients
Severe hypoglycaemia ups risk of adverse outcomes in older patients
01 Oct 2021

Severe hypoglycaemia is a risk factor for hospitalization and mortality among older patients with diabetes, a study reports. The event may also serve as a marker of future cardiovascular events among those with pre-existing heart disease and obesity.

Severe hypoglycaemia ups risk of adverse outcomes in older patients
01 Oct 2021
Blood pressure variability implicated in dementia risk
Blood pressure variability implicated in dementia risk
01 Oct 2021
DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension
DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension
28 Sep 2021 bởiJairia Dela Cruz

In the treatment of patients with type 2 diabetes mellitus and hypertension, switching from a dipeptidyl peptidase-4 (DPP-4) inhibitor to the sodium-glucose cotransporter-2 (SGLT2) inhibitor luseogliflozin appears to have favourable effects on blood pressure (BP), circadian rhythm, and night-time systolic BP (SBP) and pulse rate (PR), according to data from the open-label LUNA trial.

DPP-4–to–SGLT2 inhibitor switch confers multiple benefits for patients with diabetes, hypertension
28 Sep 2021